Metagenomi, Inc. Common Stock (MGX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Metagenomi, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -0.69x | -1.73x | -5.66x | -8.86x | -2.85x |
| P/B Ratio | 0.38x | 0.58x | 1.80x | -5.19x | -1.88x |
| P/S Ratio | 2.39x | 2.58x | 8.63x | 22.46x | 251.58x |
| Profitability | |||||
| Gross Margin | 78.9% | 100.0% | -110.9% | 89.9% | -59.3% |
| Operating Margin | -380.9% | -170.0% | -175.4% | -259.5% | -9854.7% |
| Net Margin | -348.5% | -149.3% | -152.5% | -253.4% | -8823.9% |
| EBITDA Margin | -359.8% | -159.7% | -166.0% | -227.9% | -8540.3% |
| Liquidity | |||||
| Current Ratio | 7.22x | 6.91x | 4.04x | 7.56x | 4.33x |
| Quick Ratio | 7.22x | 6.91x | 4.04x | 7.56x | 4.33x |
| Leverage | |||||
| Debt/Equity | 0.26x | 0.19x | 0.22x | -0.25x | -1.50x |
YoY = year-over-year change. Source: FMP..